Neurobiological similarities in depression
and drug dependence: a
self-medication hypothesis
by
Markou A, Kosten TR, Koob GF
Department of Neuropharmacology,
Scripps Research Institute,
La Jolla,
California 92037, USA.
Neuropsychopharmacology 1998 Mar; 18(3):135-74
ABSTRACT
Epidemiological and clinical data indicate high comorbidity between
depression and drug dependence that may reflect an attempt to self-medicate with
drugs of abuse. The present review examines whether these two psychiatric
disorders are related by attempting to identify similarities in the neurobiology
of depression and drug dependence. Emphasis is put on the neuromechanisms that
may mediate specific core symptoms of both disorders that reflect alterations in
reward and motivational processes. First, the epidemiological and clinical data
on the comorbidity of the two disorders are reviewed briefly. Then, the
neuroadaptations associated with psychomotor stimulant, opiate, ethanol,
nicotine, and benzodiazepine dependence in animals are reviewed. Finally, the
neurotransmitter systems whose function appears to be altered in depression
(i.e., serotonin, norepinephrine, acetylcholine, dopamine, gamma-aminobutyric
acid, corticotropin releasing factor, neuropeptide Y, and somatostatin), as
revealed primarily by animal studies, are discussed. It is concluded that drug
dependence and depression may be associated with alterations in some of the same
neurotransmitter systems and, in particular, with alterations of
neurotransmitter function in limbic-related brain structures. Thus, these two
psychiatric disorders may be linked by some shared neurobiology. Nevertheless,
it remains unclear whether drug abuse and depression are different symptomatic
expressions of the same preexisting neurobiological abnormalities, or whether
repeated drug abuse leads to the abnormalities mediating depression (i.e.,
drug-induced depressions). The hypothesis of self-medication of non-drug- and
drug-induced depressions with drugs of abuse is also discussed as a potentially
important explanatory concept in understanding the observed clinical comorbidity
of these two psychiatric disorders.
CRF
Reward
Alcohol
Cocaine
Cannabis
Dopamine
Anhedonia
Future Opioids
Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family